What Healthcare Leaders Need to Know Before Deploying an AI Agent
Agentic AI is no longer a concept that health systems are evaluating. It is a technology they are deploying.
Prior authorisation queues that once required coordinators making phone calls are now being handled by autonomous agents. Revenue cycle workflows that absorbed entire departments are being compressed by systems that monitor, flag, and escalate without human input at each step.
Supply chains are being managed by agents that watch inventory in real time and place orders before the shortage happens.
The momentum is real. So is the risk of moving faster than the governance infrastructure can support.
Gartner has projected that more than 40 percent of agentic AI projects will be cancelled by 2027, citing escalating costs, unclear business value, and inadequate risk controls. (Source: Skan AI Healthcare Operations AI Governance Guide 2026 — skan.ai/blogs/healthcare-operations-management-ai-governance-guide-2026-skan-ai/) That cancellation rate is not a technology failure. It is a planning failure. Organisations that deploy an AI agent without first answering the right governance questions are building on an unstable foundation.
This Guide addresses those questions directly, before the contract is signed.
Understand What an AI Agent Actually Does
Most healthcare leaders have a reasonably clear picture of what traditional AI does. It takes an input and produces an output. A model reviews a claim and flags it. A system analyses a document and surfaces relevant information. A human receives the output and acts on it.
An AI agent is different in one fundamental way. It receives a goal and pursues it across multiple steps, using tools, accessing data, making intermediate decisions, and taking actions, without human input at each individual step.
A prior authorisation agent, for example, does not simply score an authorisation request. It retrieves the relevant payer policy, checks supporting documentation, submits the request, monitors for a response, and either confirms the approval or escalates the denial. The coordinator set the goal. The agent completed the workflow.
This distinction matters for governance. When a traditional AI model makes an error, the error is typically visible at the point where the human receives the output. When an agent makes an error, that error may occur at any point in a multi-step workflow, and it may be compounded by subsequent steps before anyone notices it. The accountability question changes completely.
Define Scope Before Anything Else
The single most important governance decision in an agentic AI deployment is defining what the agent is authorised to do and, just as critically, what it is not.
An agent deployed for prior authorisation should not have access to systems outside the scope of that workflow. An agent managing supply chain reordering should not be able to modify clinical protocols, even if access to those protocols would help it make better reordering decisions. Scope boundaries need to be defined explicitly and enforced technically, not simply documented in a policy.
A practical test: can your team describe, in precise terms, every system the agent can access, every action it can take, and every circumstance in which it is required to stop and escalate to a human? If the answer is not clearly yes, the scope has not been defined sufficiently for production deployment.
Health IT Answers published an article in September 2026 naming this as the central governance challenge of agentic AI in healthcare operations: organisations need to know who owns what, gain visibility across connected workflows, and determine when human expertise needs to inform or override AI choices. (Source: healthitanswers.net/the-governance-challenge-of-agentic-ai-in-healthcare-operations/)
Build Auditability Into the Infrastructure, Not Onto It
One of the most common and costly mistakes in agentic AI deployment is treating auditability as a reporting layer added after the system is running.
Auditability needs to be embedded in the architecture from the beginning. Every action an agent takes needs to be captured in a structured, tamper-evident format that records what the agent did, what data it acted on, when it acted, and what conditions triggered the action. This record needs to be retrievable on demand, in a form that regulators, auditors, and legal counsel can use.
Clearwater Security's July 2026 analysis of agentic AI regulatory risk made the enforcement picture clear: existing HIPAA, malpractice, and non-discrimination law already reach the conduct of autonomous AI systems. The Office for Civil Rights' Phase 3 audits, currently underway across 50 entities, are finding incomplete risk analysis as the most common gap. No new agentic-specific regulation is required for an organisation to be exposed. (Source: clearwatersecurity.com/blog/agentic-ai-regulatory-uncertainty-governance/)
Building auditability after the fact is significantly more expensive than building it in from the start, and it is often architecturally impractical once an agent is in production.
This is the infrastructure problem that T.A.E.S., Tamamie's AI Event Standard, addresses directly.
T.A.E.S. embeds event tracking, governance, and auditability into the streaming and data architectures healthcare organisations are already running, ensuring that every AI-derived event is reconstructable and defensible without requiring a full infrastructure rebuild.
Establish Human Oversight That Actually Functions
Every agentic AI deployment in healthcare should have defined human oversight. The challenge is that most governance frameworks design oversight that looks appropriate on paper but fails in practice.
A multidisciplinary review committee that meets every few weeks is not a functioning oversight mechanism for a system making hundreds of decisions per day. David Talby of John Snow Labs, speaking at a 2026 presentation documented by ODSC, identified this exact failure mode: the traditional manual oversight model cannot scale to the volume and speed at which agentic systems operate. (Source: odsc.medium.com/governing-agentic-ai-a-blueprint-for-safe-compliant-healthcare-agents-in-production-b0897b98ae59/)
Functional oversight in an agentic AI environment looks different. It means automated monitoring that surfaces anomalies in real time, not in the next committee meeting. It means defined escalation pathways where the agent hands off to a human when it encounters a condition outside its designed scope. It means clear accountability for who reviews the escalation, acts on it, and documents the outcome.
The oversight structure needs to be designed for the operating speed of the system, not for the operating speed of a human committee.
Validate Performance in Your Environment, Not the Vendor's
Vendor performance data is not sufficient evidence that an agentic AI system will perform reliably in your organisation.
AI agents perform differently across environments depending on data quality, workflow configuration, integration architecture, and the specific population of cases they encounter. A system that performs at a documented accuracy rate in a controlled test environment or at a peer institution may perform materially differently in your operational context.
A 2026 multicenter validation study of a widely-used prediction model, referenced in a governance conditions analysis by OneReach AI, found accuracy that was variable enough across sites that the authors recommended local validation before any organisation relied on it in production. (Source: onereach.ai/blog/ai-agents-in-healthcare-the-governance-conditions-that-matter/) The same principle applies to agents.
Local validation before production deployment is not an optional step. It is the step that determines whether the performance you are deploying matches the performance you were sold.
Know What Happens When Something Goes Wrong
Before an agentic AI system goes live, the organisation should have a complete, documented response process for the scenarios that will eventually occur.
What happens when the agent takes an action that produces an incorrect outcome? Who has authority to suspend the system? How is the extent of any downstream impact assessed? How is the incident documented for potential regulatory reporting? How are affected parties notified?
Most healthcare incident response plans were written for internal system failures and external breaches. They were not written for the specific scenario of an autonomous agent making a consequential decision that needs to be traced, contained, and corrected. That gap needs to be closed before the first deployment, not discovered during the first incident.
The Organisations That Get This Right
The clearest differentiator between agentic AI deployments that deliver measurable operational value and those that are cancelled or rolled back is not the sophistication of the technology. It is the quality of the governance decisions made before deployment.
Organisations that define scope precisely, build auditability in from the start, design oversight that operates at the speed of the system, validate in their own environment, and plan for failure before it happens are the ones that reach production and stay there.
The infrastructure decisions made in the first agentic AI deployment shape every deployment that follows. Building them on a foundation of rigorous governance is not the slow path. It is the only path that leads to sustainable operational transformation.
Tamamie builds the intelligent infrastructure that powers the next generation of healthcare operations. T.A.E.S., Tamamie's AI Event Standard, provides the accountability and auditability layer that makes agentic AI deployment safe to scale across health systems, pharmaceutical organisations, and public health environments. Learn more at tamamie.com
Comments